Rekombinanter IL-6R (Tocilizumab Biosimilar) Antikörper

Produktnummer ABIN7487791

Produktdetails anti-IL-6R (Tocilizumab Biosimilar) Antikörper

Target: IL-6R (Tocilizumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Mammalian Cells

Expressionssystem: Mammalian cells

Klonalität: Monoklonal

Konjugat: Dieser IL-6R (Tocilizumab Biosimilar) Antikörper ist unkonjugiert

Applikation: ELISA

Verwendungszweck: Tocilizumab Biosimilar - Anti-IL-6R mAb

Produktmerkmale: Antibody Type: IgG1Kappa

Aufreinigung: Recombinant antibody expressed in mammalien cells and purified.

Güteklasse: Research Grade

Isotyp: IgG1 kappa

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: PBS pH 7.5

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: 4°C for short term, -20°C for long term

Details zu IL-6R (Tocilizumab Biosimilar)

Target: IL-6R (Tocilizumab Biosimilar)

Abstract: IL-6R (Tocilizumab Biosimilar) Produkte

Synonyme: CD126 antikoerper, IL-6R-1 antikoerper, IL-6RA antikoerper, IL6Q antikoerper, IL6RA antikoerper, IL6RQ antikoerper, gp80 antikoerper, interleukin 6 receptor antikoerper, IL6R antikoerper

Substanzklasse: Biosimilar

Hintergrund: Tocilizumab
Tocilizumab, also known as atlizumab, is a recombinant humanized, anti-human monoclonal antibody (mAb) of the immunoglobulin G1κ subclass directed against soluble and membrane-bound interleukin-6 (IL-6) receptor (IL-6R) which plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer.

CAS-Nummer: 375823-41-9